HOME BRAIN CANCER AUTOLITT® ADVANTAGES PHYSICIANS COMPANY CONTACT
  Expand / Contract


ADVANTAGES

previous page / next page
The AutoLITT® System is an investigational device, not yet tested in humans. Clinical studies are planned in 2008 and 2009 to explore the potential of the AutoLITT therapy to have distinct advantages in the treatment of brain tumors in certain situations, including:
 
Less risk of complications
Fewer side effects
Faster recovery

“Immediate” complete tumor death
 

previous page / next page

secure login
© Copyright Monteris Medical All rights reserved.